Rapid Micro Biosystems, Inc. (RPID)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 16 | 23 | 17 | 23 | 28 | 34 | 35 | 39 |
| Operating profit | $m | -47 | -50 | ||||||
| Net profit | $m | -37 | -74 | -61 | -52 | -47 | -47 | -51 | -42 |
| EPS reported | $ | -1.05 | -1.11 | ||||||
| Operating cashflow per share | $ | -0.70 | -0.85 | ||||||
| Capex per share | $ | 0.02 | 0.01 | ||||||
| FCF per share | $ | -0.71 | -0.86 | ||||||
| Free cash flow | $m | -32 | -40 | ||||||
| Net debt | $m | -19 | -1 | ||||||
| Book value equity | $m | 33 | 18 | ||||||
| Book value per share | $ | 0.74 | 0.38 | ||||||
| Number of shares | m | 44.68 | 47.01 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 3.90 | 7.30 | ||||||
| P/S LTM | x | 3.86 | 3.68 | ||||||
| P/FCF LTM | x | -4.06 | -3.21 | ||||||
| EV/EBITDA LTM | x | -3.12 | -2.88 | ||||||
| EV/Sales LTM | x | 3.97 | 2.41 | ||||||
| Earnings Yield LTM | % | -36.37% | -64.83% | ||||||
| FCF Yield | % | -24.63% | -31.17% | ||||||
| Quality | |||||||||
| ROE | % | -141.91% | -177.04% | ||||||
| ROIC | % | -82.19% | -1.19% | ||||||
| Operating margin | % | -1.41% | -1.41% | ||||||
| Gross margin | % | +22.65% | +10.03% | ||||||
| FCF/Sales | % | -95.01% | -114.83% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +19.74% | +25.40% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -1.34 | -1.72 | ||||||
| Net Debt/EBITDA | x | -0.09 | -0.19 | ||||||
| EBIT/Net interest | x | -43.48 | -19.82 | ||||||
| Net debt/market cap | % | +14.59% | +25.14% | ||||||
| Net debt/Equity | x | -0.58 | -0.04 | ||||||
| Gross debt/equity | x | 0.72 | 1.32 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Rapid Micro Biosystems, Inc. (RPID)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free